Philips announces European availability of innovations to advance personalized and efficient cardiac care at EuroPCR 2021
18 Mai 2021 - 10:00AM
Philips announces European availability of innovations to advance
personalized and efficient cardiac care at EuroPCR 2021
May 18, 2021
Amsterdam, the Netherlands – Royal Philips
(NYSE: PHG, AEX: PHIA), a global leader in health technology, today
announced the European availability of new innovations in its
unique portfolio of solutions that integrate imaging, devices,
software, informatics and services at each point in a cardiac
patient’s journey at EuroPCR 2021 (May 18-20). During the virtual
event, Philips is showcasing its latest innovations in image-guided
therapy that advance procedures including percutaneous coronary
interventions (PCI) to treat the narrowing of coronary
arteries.
“At Philips we envision personalized, efficient and
clinically-smart cardiac care that drives optimal outcomes
throughout the patient journey,” said Bert van Meurs, Chief
Business Leader for Image Guided Therapy at Philips. “At this
year’s virtual EuroPCR we’re showcasing how we bring together
devices, systems, software and services that improve cardiac care
by strengthening clinical confidence, building efficiency
throughout the care pathway and improving the experience for both
patients and staff.”
Philips Interventional Applications Platform
– IntraSight MobileThe new Philips Interventional
Applications Platform – IntraSight Mobile – brings together imaging
and physiology applications on a mobile system for coronary and
peripheral artery disease therapy [1]. IntraSight Mobile builds on
the success of IntraSight, integrating intravascular diagnostic
applications into a smart, simple, and seamless workflow solution
for interventional labs.
The IntraSight platform allows interventional cardiologists to
perform intravascular ultrasound (IVUS) imaging and physiologic
measurements of fractional flow reserve (FFR) and instant wave-free
ratio (iFR) to accurately identify the location of lesions causing
ischemia. IntraSight Mobile is built on the same software as
IntraSight and is compatible with Philips’ current and future
portfolio of IVUS and physiology disposables. It includes a
touchscreen panel PC and a ruggedized multi-modality touch screen
module mounted on a modern and easy to maneuver cart. Its intuitive
user interface and simplified workflow offer clinicians an
outstanding user experience while also optimizing lab
performance.
European debut of Philips OmniWire Pressure Guide
WirePhilips OmniWire Pressure Guide Wire, the world’s
first solid-core pressure wire for coronary artery interventions,
has received CE marking and is now available in Europe [2]. With
its breakthrough solid-core construction, physicians can more
easily maneuver the wire in the patient’s circulatory system to
measure blood pressure along the vessel and guide the delivery of
catheters and stents. OmniWire supports iFR and FFR measurements,
which can be co-registered onto angiograms to precisely identify
the parts of a vessel that require treatment.
Introduction of Philips Laser SystemThe new
Philips Laser System offers plug-and-play simplicity for coronary
and peripheral atherectomy procedures. The catheters compatible
with the Philips Laser System are indicated in more vessel types
than any other atherectomy device, and it is the only laser
atherectomy technology proven for in-stent restenosis (ISR) in both
coronary and peripheral vasculature [3,4]. In addition, the system
is also the only laser system available for lead extraction
procedures (the removal of pacemaker or defibrillator leads around
the heart). Smaller, lighter and more maneuverable, the system
starts up within 30 seconds and has an intuitive touch-screen
interface with guided workflow prompts that minimize the need for
technician training.
Also being showcased at EuroPCR is the recently-introduced
Philips Interventional Hemodynamic System with Patient Monitor
IntelliVue X3 which provides advanced hemodynamic (blood flow)
measurements at the tableside in the cath lab and continuous
monitoring of key vital signs throughout the patient journey. In
addition, Philips Cardiovascular Imaging and Information Manager –
IntelliSpace Cardiovascular – supports informed decision-making by
providing a comprehensive overview of the patient’s cardiovascular
care continuum and helps save time and unnecessary work and
significantly improves efficiency and workflow.
As demands on cardiology departments continue to increase,
clinicians and administrators are balancing the delivery of
high-quality care and optimal outcomes with pressure to increase
efficiency and care for more patients. Definitive diagnostics,
innovative procedures, and personalized patient management are
essential to helping address these demands. Philips provides a
unique portfolio of solutions centered on its next-generation Image
Guided Therapy System – Azurion. Individually, the company’s
innovations help to solve some of cardiology’s most significant
daily challenges, and together they connect throughout the care
pathway to create a powerful ecosystem that helps realize the
vision of delivering better cardiac care with greater efficiency.
For more information visit www.philips.com/cardiology.
[1] Philips Mobile Interventional Applications Platform –
IntraSight Mobile – is CE marked for sale in Europe and has
received FDA 510(k) clearance for sale in the U.S.[2] Philips
Pressure Guide Wire – OmniWire – is CE marked for sale in Europe
and has received FDA 510(k) clearance for sale in the U.S.[3]
Philips Laser System is CE marked for sale in Europe. The system is
not currently available for sale in the U.S.[4] ISR indicated for
ELCA (P002208) and the Turbo-Power (P015612)
For further information, please contact:
Mark GrovesPhilips Global Press OfficeTel.: +31 631 639
916E-mail: mark.groves@philips.com
Fabienne van der FeerPhilips Image Guided TherapyTel: + 31 622
698 001E-mail : fabienne.van.der.feer@philips.com
About Royal Philips
Royal Philips (NYSE: PHG, AEX: PHIA) is a leading health
technology company focused on improving people's health and
well-being, and enabling better outcomes across the health
continuum – from healthy living and prevention, to diagnosis,
treatment and home care. Philips leverages advanced technology and
deep clinical and consumer insights to deliver integrated
solutions. Headquartered in the Netherlands, the company is a
leader in diagnostic imaging, image-guided therapy, patient
monitoring and health informatics, as well as in consumer health
and home care. Philips generated 2020 sales of EUR 17.3 billion and
employs approximately 77,000 employees with sales and services in
more than 100 countries. News about Philips can be found at
www.philips.com/newscenter.
- Philips Azurion PCI procedure
- Philips Laser System
- Philips OmniWire Pressure Guide Wire 3D view
Koninklijke Philips NV (BIT:1PHIA)
Historical Stock Chart
Von Feb 2024 bis Mär 2024
Koninklijke Philips NV (BIT:1PHIA)
Historical Stock Chart
Von Mär 2023 bis Mär 2024